Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | Cfo & Cbo | $493K | -$53K | -9.71% | Nov 7, 2024 |
FULC | Fulcrum Therapeutics, Inc. | Chief Financial Officer | Feb 9, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|